Genetic risk score analysis in early-onset bipolar disorder

Journal of Clinical Psychiatry

Volumn 78, Issue 9, 2017, Pages 1337-1343

  Croarkin, Paul E ^a   Luby, Joan L ^b   Cercy, Kelly ^a   Geske, Jennifer R ^a   Veldic, Marin ^a   Simonson, Matthew ^a   Joshi, Paramjit T ^c   Wagner, Karen Dineen ^d   Walkup, John T ^e   Nassan, Malik M ^a   Cuellar Barboza, Alfredo B ^f   Casuto, Leah ^g   McElroy, Susan L ^g   Jensen, Peter S ^h   Frye, Mark A ^a   Biernacka, Joanna M ^a  

^a MAYO CLINIC   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^g LINDNER CENTER OF HOPE   (United States)

^h REsource for Advancing Children's Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ANKYRIN 3; CALCIUM CHANNEL; MEMBRANE PROTEIN; TENEURIN TRANSMEMBRANE PROTEIN 4; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT CALCIUM CHANNEL L TYPE ALPHA1C SUBUNIT;

ADULT; ANK3 GENE; ARTICLE; BIPOLAR DISORDER; CACNA1C GENE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DSM-IV; FEMALE; GENE LOCUS; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; ODZ4 GENE; ONSET AGE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; CASE CONTROL STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; PRESCHOOL CHILD; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 85037601312     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m10314     Document Type: Article

References (50)

1. Leboyer M, Henry C, Paillere-Martinot ML, et al. Age at onset in bipolar affective disorders: a review. Bipolar Disord. 2005;7(2):111–118.
2. Geller B, Tillman R, Bolhofner K, et al. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. ArchGenPsychiatry. 2008;65(10):1125–1133.
3. Etain B, Dumaine A, Mathieu F, et al. A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain. MolPsychiatry. 2010;15(7):748–755.
4. Faraone SV, Biederman J, Wozniak J. Examining the comorbidity between attention deficit hyperactivity disorder and bipolar I disorder: a meta-analysis of family genetic studies. Am J Psychiatry. 2012;169(12):1256–1266.
5. Merikangas KR, Nakamura EF, Kessler RC. Epidemiology of mental disorders in children and adolescents. Dialogues Clin Neurosci. 2009;11(1):7–20.
6. Pauls DL, Morton LA, Egeland JA. Risks of affective illness among first-degree relatives of bipolar I old-order Amish probands. ArchGen Psychiatry. 1992;49(9):703–708.
7. Grigoroiu-Serbanescu M, Martinez M, Nöthen MM, et al. Different familial transmission patterns in bipolar I disorder with onset before and after age 25. AmJMedGenet. 2001;105(8):765–773.
8. Bellivier F, Golmard JL, Rietschel M, et al. Age at onset in bipolar I affective disorder: further evidence for three subgroups. AmJPsychiatry. 2003;160(5):999–1001.
9. Post RM, Leverich GS, Kupka RW, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. JClinPsychiatry. 2010;71(7):864–872.
10. Nurnberger JI Jr, Koller DL, Jung J, et al; Psychiatric Genomics Consortium Bipolar Group. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry. 2014;71(6):657–664.
11. Sklar P, Smoller JW, Fan J, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008;13(6):558–569.
12. Ferreira MA, O’Donovan MC, Meng YA, et al; Wellcome Trust Case Control Consortium. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008;40(9):1056–1058.
13. Dao DT, Mahon PB, Cai X, et al; Bipolar Genome Study (BiGS) Consortium. Mood disorder susceptibility gene CACNA1Cmodifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosi in humans. BiolPsychiatry. 2010;68(9):801–810.
14. Durak O, de Anda FC, Singh KK, et al. Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin. MolPsychiatry. 2015;20(3):388–397.
15. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. NatGenet. 2011;43(10):977–983.
16. Mühleisen TW, Leber M, Schulze TG, et al. Genome-wide association study reveals two new risk loci for bipolar disorder. NatCommun. 2014;5:3339.
17. Chang K, Adleman NE, Dienes K, et al. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Arch Gen Psychiatry. 2004;61(8):781–792.
18. Singh MK, Kelley RG, Howe ME, et al. Reward processing in healthy offspring of parents with bipolar disorder. JAMA Psychiatry. 2014;71(10):1148–1156.
19. Geller B, Luby JL, Joshi P, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. ArchGenPsychiatry. 2012;69(5):515–528.
20. Olson JE, Ryu E, Johnson KJ, et al. The Mayo Clinic Biobank: a building block for individualized medicine. MayoClinProc. 2013;88(9):952–962.
21. Geller B, Williams M, Zimerman B, et al. Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS). St Louis, MO: Washington University; 1996.
22. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
23. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Patient Edition (SCID-I/P). New York, NY: Biometrics Research, New York State Psychiatri Institute; 2002.
24. Etain B, Mathieu F, Rietschel M, et al. Genome-wide scan for genes involved in bipolar affecti disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14. Mol Psychiatry. 2006;11(7):685–694.
25. Jamain S, Cichon S, Etain B, et al. Common and rare variant analysis in early-onset bipolar disorder vulnerability. PLoSOne. 2014;9(8):e104326.
26. Frye MA, McElroy SL, Fuentes M, et al. Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses. IntJBipolarDisord. 2015;3(1):30.
27. Cuellar-Barboza AB, Winham SJ, McElroy SL, et al. Accumulating evidence for a role of TCF7L2 variants in bipolar disorder with elevated bod mass index. Bipolar Disord. 2016;18(2):124–135.
28. Che R, Motsinger-Reif AA. Evaluation of geneti risk score models in the presence of interactio and linkage disequilibrium. FrontGenet. 2013;4:138.
29. Green EK, Hamshere M, Forty L, et al; WTCCC. Replication of bipolar disorder susceptibility alleles and identification of two novel genom wide significant associations in a new bipolar disorder case-control sample. MolPsychiatry. 2013;18(12):1302–1307.
30. Schaid DJ, Rowland CM, Tines DE, et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. AmJHumGenet. 2002;70(2):425–434.
31. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265.
32. Abecasis GR, Auton A, Brooks LD, et al; 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56–65.
33. Moskvina V, Craddock N, Holmans P, et al; Wellcome Trust Case Control Consortium. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. MolPsychiatry. 2009;14(3):252–260.
34. Bigos KL, Mattay VS, Callicott JH, et al. Genetic variation in CACNA1Caffects brain circuitries related to mental illness. ArchGenPsychiatry. 2010;67(9):939–945.
35. Kerner B. Genetics of bipolar disorder. ApplClin Genet. 2014;7:33–42.
36. Gershon ES, Grennan K, Busnello J, et al. A rare mutation of CACNA1Cin a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1Cin brain. MolPsychiatry. 2014;19(8):890–894.
37. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381(9875):1371–1379.
38. Insel TR, Cuthbert BN. Medicine. Brain disorders? Precisely. Science. 2015;348(6234):499–500.
39. Clementz BA, Sweeney JA, Hamm JP, et al. Identification of distinct psychosis biotypes using brain-based biomarkers. AmJPsychiatry. 2016;173(4):373–384.
40. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013;381(9878):1654–1662.
41. Craddock N, Sklar P. Genetics of bipolar disorder: successful start to a long journey. Trends Genet. 2009;25(2):99–105.
42. Faraone SV, Glatt SJ, Tsuang MT. The genetics o pediatric-onset bipolar disorder. BiolPsychiatry. 2003;53(11):970–977.
43. Bellivier F, Etain B, Malafosse A, et al. Age at onset in bipolar I affective disorder in the USA and Europe. WorldJBiolPsychiatry. 2014;15(5):369–376.
44. Carlson GA. Diagnostic stability and bipolar disorder in youth. JAmAcadChildAdolesc Psychiatry. 2011;50(12):1202–1204.
45. Kennedy KP, Cullen KR, DeYoung CG, et al. The genetics of early-onset bipolar disorder: a systematic review. J Affect Disord. 2015;184:1–12
46. Sparks GM, Axelson DA, Yu H, et al. Disruptive mood dysregulation disorder and chronic irritability in youth at familial risk for bipolar disorder. JAmAcadChildAdolescPsychiatry. 2014;53(4):408–416.
47. Gonzalez S, Xu C, Ramirez M, et al. Suggestive evidence for association between L-type voltage-gated calcium channel (CACNA1C) gene haplotypes and bipolar disorder in Latinos: a family-based association study. Bipolar Disord. 2013;15(2):206–214.
48. Ruderfer DM, Fanous AH, Ripke S, et al; Schizophrenia Working Group of Psychiatric Genomics Consortium; Bipolar Disorder Working Group of Psychiatric Genomics Consortium; Cross-Disorder Working Group of Psychiatric Genomics Consortium. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry. 2014;19(9):1017–1024.
49. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421–427.
50. Wang H, Haiman CA, Kolonel LN, et al. Self-reported ethnicity, genetic structure and the impact of population stratification in a multiethnic study. Hum Genet. 2010;128(2):165–177.